pentetic acid has been researched along with Carcinoma, Transitional Cell in 10 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-eight patients with urinary bladder neoplasms were examined with magnetic resonance imaging before and after intravenous administration of gadolinium diethylene-triaminepentaacetic acid (DTPA)." | 3.67 | Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. ( Bohndorf, K; Daus, HJ; Guenther, RW; Neuerburg, JM; Sohn, M; Teufl, F, 1989) |
| "Urinary bladder cancer started to enhance 6." | 1.29 | Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. ( Barentsz, JO; Jager, GJ; Karssemeijer, N; Peters, H; Ruijs, SH; Strijk, SP; van Vierzen, PB; Witjes, JA, 1996) |
| "Staging of superficial bladder cancer was more accurate with dynamic contrast-enhanced MRI than with conventional MRI (P = 0." | 1.29 | [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. ( Ebert, T; Felix, R; Friedrichs, R; Hierholzer, J; Hosten, N; Ilg, J; Venz, S, 1996) |
| "A total of 57 bladder cancer patients was evaluated." | 1.28 | Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonogra ( Baba, S; Deguchi, N; Hata, M; Hiramatsu, K; Jitsukawa, S; Tachibana, M; Tanimoto, A; Tazaki, H; Yuasa, Y, 1991) |
| "In 60 patients with suspected or proved bladder tumors, the results of preoperative gadolinium-enhanced MRI were correlated with the histopathologic findings." | 1.28 | Gadolinium-enhanced magnetic resonance imaging in the staging of urinary bladder neoplasms. ( Bohndorf, K; Neuerburg, J; Sohn, M; Teufl, F, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carr, DH | 2 |
| Brown, J | 1 |
| Bydder, GM | 1 |
| Steiner, RE | 1 |
| Weinmann, HJ | 1 |
| Speck, U | 1 |
| Hall, AS | 1 |
| Young, IR | 1 |
| Tempany, CM | 1 |
| Masoudi, FA | 1 |
| Marshall, FF | 1 |
| Kim, B | 1 |
| Semelka, RC | 1 |
| Ascher, SM | 1 |
| Chalpin, DB | 1 |
| Carroll, PR | 1 |
| Hricak, H | 1 |
| Barentsz, JO | 1 |
| Jager, GJ | 1 |
| van Vierzen, PB | 1 |
| Witjes, JA | 1 |
| Strijk, SP | 1 |
| Peters, H | 1 |
| Karssemeijer, N | 1 |
| Ruijs, SH | 1 |
| Venz, S | 1 |
| Ilg, J | 1 |
| Ebert, T | 1 |
| Hierholzer, J | 1 |
| Friedrichs, R | 2 |
| Hosten, N | 1 |
| Felix, R | 2 |
| Kaminsky, S | 1 |
| Gogoll, M | 1 |
| Neumann, K | 1 |
| Nagel, R | 1 |
| Tachibana, M | 1 |
| Baba, S | 1 |
| Deguchi, N | 1 |
| Jitsukawa, S | 1 |
| Hata, M | 1 |
| Tazaki, H | 1 |
| Tanimoto, A | 1 |
| Yuasa, Y | 1 |
| Hiramatsu, K | 1 |
| Sohn, M | 2 |
| Neuerburg, J | 1 |
| Teufl, F | 2 |
| Bohndorf, K | 2 |
| Neuerburg, JM | 1 |
| Guenther, RW | 1 |
| Daus, HJ | 1 |
1 trial available for pentetic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
The use of dynamic magnetic resonance imaging to evaluate orthotopic continent urinary diversion.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Case-Control Studies; Contrast Media; Cystectomy; Gadolin | 1995 |
9 other studies available for pentetic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.
Topics: Abdomen; Adult; Aged; Brain; Brain Neoplasms; Carcinoma, Transitional Cell; Contrast Media; Drug Eva | 1984 |
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Topics: Carcinoma, Transitional Cell; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Ma | 1994 |
Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging.
Topics: Biopsy; Carcinoma, Transitional Cell; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hu | 1996 |
[Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Contrast Media; Cystectomy; Cystitis; Female; Gadolinium | 1996 |
[Bladder tumors--Magnevist-assisted magnetic resonance tomography].
Topics: Aged; Aged, 80 and over; Animals; Carcinoma, Transitional Cell; Contrast Media; Cystitis; Female; Ga | 1992 |
Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonogra
Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Transitional Cell; Female; Gadolinium | 1991 |
Gadolinium-enhanced magnetic resonance imaging in the staging of urinary bladder neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Carcinoma, Transitional Ce | 1990 |
Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Contrast Media; Female; Gadolinium; Ga | 1989 |
The use of proton relaxation enhancers in magnetic resonance imaging.
Topics: Adenocarcinoma; Animals; Astrocytoma; Brain Neoplasms; Carcinoma, Transitional Cell; Cerebellar Neop | 1985 |